Preparation method of ciclesonide

The technology of a ciclesonide and a synthesis method is applied in the field of preparation of a glucocorticoid-type asthma therapeutic drug ciclesonide, and can solve the problems of difficult separation of impurities, low yield, expensive raw materials for ciclesonide reaction, and the like, To achieve the effect of reducing production cost, high yield and beneficial to industrial production

Inactive Publication Date: 2018-03-09
TIANJIN PACIFIC PHARMA
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The technical problem to be solved by the present invention is aimed at the problems in the prior art that the ciclesonide reaction raw material is relatively expensive, and the yield is low, and impurities are not easy to separate.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of ciclesonide
  • Preparation method of ciclesonide
  • Preparation method of ciclesonide

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0033] The invention discloses a preparation method of ciclesonide, and those skilled in the art can learn from the content of this paper and appropriately improve the process parameters to achieve. It should be specially pointed out that all similar substitutions and modifications are obvious to those skilled in the art, they are all considered to be included in the present invention, and relevant persons can obviously do so without departing from the content, spirit and scope of the present invention. The content described herein can be modified or appropriately changed and combined to realize and apply the technology of the present invention.

[0034] In the present invention, unless otherwise specified, scientific and technical terms used herein have the meanings commonly understood by those skilled in the art.

Embodiment 1

[0036] Example 1: Preparation of compound of formula II

[0037]

[0038]At the temperature of -5~5℃, 100mL methanol was used as the solvent, the reaction flask was placed in an ice-water bath to control the low temperature, 5.4g (17.5mmol) of compound I, 4.2g (105mmol) of sodium hydroxide were added to the reaction flask, and stirred for 10~ 30min, under the dark condition, add 8.5g (26.3mmol) iodobenzene diacetate at one time, naturally rise to room temperature and react for 6~8 hours, monitor the reaction progress by TLC, drip 20g (141mmol) iodomethane, continue the reaction, wait for After the reaction, the solvent was removed under reduced pressure, extracted with 100 mL of ethyl acetate and 20 mL of water, the organic phase was washed with water, dried over anhydrous sodium sulfate, and the solvent was removed under reduced pressure to obtain 6.3 g (16.3 mmol) of the compound of formula II with a yield of 93 %.

Embodiment 2

[0039] Example 2: Preparation of compound of formula III

[0040]

[0041] 150 mL of acetone was used as a solvent, 7.1 g (18.4 mmol) of the compound of formula II was added, the temperature was lowered to -5 to 5 °C, 2.8 mL of about 3.4 g (73.4 mmol) of formic acid was added as a catalyst, and 5.2 g (33.1 mmol) of potassium permanganate were added. Oxidation reaction, TLC monitoring reaction progress, after the reaction is completed, the excess potassium permanganate is treated with saturated sodium sulfite solution, the insoluble solid is removed by filtration, washed with acetone, decolorized with activated carbon, the solid is removed by filtration, the solvent is removed under reduced pressure, and the pure water is recrystallized to obtain formula III Compound 6.8 g (16.2 mmol), 88% yield.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a new synthetic route for preparation of ciclesonide. The method comprises the steps that used raw materials are cheaper and available, the reaction raw materials are protectedafter hydroxylation, selective oxidation of a five-membered ring double bond is then performed, then, a six-membered ring double bond bromination is conducted, bromine atom is removed by reduction, acarbonyl group and a hydroxyl protecting group are removed, then, an oxidized dihydroxyl group is protected, the six-membered ring double bond is then epoxidized and reacts with cyclohexanecarboxaldehyde and isobutyryl chloride in turn to obtain a ciclesonide product. A reaction process is easy to operate, yield is higher in each step, purity of the obtained product is also higher, generation of by-products is effectively avoided, production cost is reduced, and the new synthetic route for the preparation of the ciclesonide is advantageous to industrial production.

Description

technical field [0001] The application relates to a preparation method of a glucocorticoid-type asthma treatment drug ciclesonide. Background technique [0002] Ciclesonide is a new type of inhaled glucocorticoid for asthma treatment, belonging to the adrenal corticosteroid class. Ciclesonide was successfully developed by the German drugmaker Altana Pharmaceuticals. The drug was first approved in Australia on December 15, 2004, and was first listed in the United Kingdom in January 2005. It has now been listed in Germany and Ireland for the treatment of adults. Persistent asthma of all severity levels. In a phase III clinical study in patients with severe, persistent asthma, ciclesonide has novel release and distribution properties that reduce local and systemic adverse effects and maintain high anti-asthmatic activity, thereby significantly reducing patient exposure to oral The need for corticosteroids (OCS) to maintain or improve asthma control. Therefore, it is an appro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07J71/00
CPCY02P20/55C07J71/0031
Inventor 宋德成
Owner TIANJIN PACIFIC PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap